Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Net Loss Per Share, Basic and Diluted

The following table sets forth reconciliation of the numerators and denominators used to compute basic and diluted net loss per share of Class A common stock for the years ended December 31, 2025, 2024, and 2023.


	Year Ended
(in thousands)	December 31, 2025			December 31, 2024			December 31, 2023
Numerator:
Net loss	$	(199,297	)	$	(591,446	)	$	(289,627	)
Less: Net loss attributable to noncontrolling interests		(60,365	)		(178,322	)		(87,239	)
Net loss attributable to Definitive Healthcare Corp.	$	(138,932	)	$	(413,124	)	$	(202,388	)

The following table sets forth the computation of basic and diluted net loss per share of Class A common stock:


	Year Ended
(in thousands, except number of shares and per share amounts)	December 31, 2025			December 31, 2024			December 31, 2023
Basic net loss per share attributable to common stockholders
Numerator:
Allocation of net loss attributable to Definitive Healthcare Corp.	$	(138,932	)	$	(413,124	)	$	(202,388	)
Weighted average number of shares of Class A outstanding		106,650,845			116,640,183			112,764,537
Net loss per share, basic and diluted	$	(1.30	)	$	(3.54	)	$	(1.79	)

Schedule of Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following table presents potentially dilutive securities which were excluded from the computation of diluted net loss per share for the periods presented because their effects on net loss per share would have been anti-dilutive:


	Year Ended
	December 31, 2025		December 31, 2024		December 31, 2023
LLC Units (vested and unvested)		38,339,076		39,439,198		39,762,700
Restricted stock units		12,222,650		9,105,791		6,828,490

Definitive Healthcare Corp. 10-K